Impact BioMedical Inc.
IBO
$0.6437
-$0.0211-3.17%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,032.36% | 95.33% | -737.99% | 579.03% | 7.80% |
| Total Depreciation and Amortization | 100.00% | -50.00% | 0.00% | 100.00% | -50.00% |
| Total Amortization of Deferred Charges | 1.42% | 1.81% | -0.72% | 0.36% | 0.00% |
| Total Other Non-Cash Items | 4,490.72% | -98.88% | 557.80% | -2,084.62% | 47.42% |
| Change in Net Operating Assets | -45.45% | 102.67% | -196.40% | -120.63% | -1,150.00% |
| Cash from Operations | -1.76% | 45.70% | 2.26% | -233.77% | 20.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -100.00% | 0.00% | -- |
| Cash from Investing | -100.00% | -- | -100.00% | 0.00% | -- |
| Total Debt Issued | -- | -- | 162.05% | -41.67% | -20.50% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -85.14% | 928.65% | -20.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.91% | -1.79% | -125.09% | -- | -100.00% |